The Use of Targeted Therapies in Patients with Inoperable Locally Advanced or Metastatic Renal Cell Cancer: Updated Guideline 2017english
The primary objective of this report is to determine the optimal targeted therapies for locally advanced or metastatic renal cell cancer (mRCC). The secondary objective is to determine whether a combination of targeted agents is better than any single targeted agent.
Adult patients with inoperable locally advanced or mRCC.
Intended Guideline Users
Oncologists who treat patients with RCC.
What are the optimal targeted therapies for locally advanced or mRCC?